Relay Therapeutics, Inc.
RLAYFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Relay Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Swiss National Bank | 2026-03-31 | 238,000 | $2.37M | SEC filing |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 2026-03-31 | 55,384 | Not shown | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 45,267 | $450K | SEC filing |
| Kalehua Capital Management LLC | 2026-03-31 | 901,457 | $8.97M | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 1,432,003 | $14.2M | SEC filing |
| QUADRANT CAPITAL GROUP LLC | 2026-03-31 | 11,791 | $117K | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 162,236 | $1.61M | SEC filing |
| PERCEPTIVE ADVISORS LLC | 2026-03-31 | 9,751,141 | $97M | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 2,541,861 | $25.3M | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 197,535 | Not shown | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 8,100 | $80.6K | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 3,510,636 | $34.9M | SEC filing |
| Y-Intercept (Hong Kong) Ltd | 2026-03-31 | 17,516 | $174K | SEC filing |
| State of New Jersey Common Pension Fund D | 2026-03-31 | 41,464 | $413K | SEC filing |
| Pictet Asset Management Holding SA | 2026-03-31 | 19,592 | $195K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 37,005 | $368K | SEC filing |
| AMERIPRISE FINANCIAL INC | 2026-03-31 | 356,924 | $3.55M | SEC filing |
| Avion Wealth | 2026-03-31 | 136 | Not shown | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 619,652 | $6.17M | SEC filing |
| IEQ CAPITAL, LLC | 2026-03-31 | 205,310 | $2.04M | SEC filing |
- Each value is checked against Relay Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Relay Therapeutics, Inc.'s share price.
- Value not shown for 2 rows: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | S — Open market or private sale | −61,563 | 16.97 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | S — Open market or private sale | −17,717 | 17.01 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | S — Open market or private sale | −56,323 | 16.97 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | S — Open market or private sale | −51,560 | 16.97 | SEC filing |
| 2026-06-22 | Bergstrom Donald A · President, R&D | Common Stock | S — Open market or private sale | −93,456 | 16.94 | SEC filing |
| 2026-05-14 | Catinazzo Thomas · Chief Financial Officer | Common Stock | S — Open market or private sale | −17,717 | 12.86 | SEC filing |
| 2026-04-28 | Rahmer Peter · See remarks | Common Stock | S — Open market or private sale | −753 | 14.79 | SEC filing |
| 2026-04-28 | Catinazzo Thomas · Chief Financial Officer | Common Stock | S — Open market or private sale | −972 | 14.79 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-22 | Bergstrom Donald A · President, R&D | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −93,456 | SEC filing |
| 2026-06-22 | Bergstrom Donald A · President, R&D | Common Stock | M — Exercise or conversion of derivative security | +93,456 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +61,563 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −51,560 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +51,560 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −61,563 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +56,323 | SEC filing |
| 2026-06-22 | Catinazzo Thomas · Chief Financial Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −56,323 | SEC filing |
Showing 8 of 23 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.